Pharma & Biotech

Crinetics Pharmaceuticals has begun the year on a high note, with its first commercial product, PALSONIFY, delivering sales that exceeded...

Investor attention is turning to Bio-Rad Laboratories as the company prepares to release its fourth-quarter and full-year 2025 financial results....

All eyes are on pharmaceutical distribution giant Cencora this week as it prepares to release its first-quarter 2026 financial results....

Elanco Animal Health is entering the new trading month with significant momentum. A combination of raised price targets from major...

As the life sciences tools sector anticipates a recovery in biotech funding, Bio-Techne is executing a strategic shift. The company...

A significant regulatory roadblock has been removed for Intellia Therapeutics. The U.S. Food and Drug Administration (FDA) has lifted the...

A significant regulatory milestone has been achieved by BioNTech in the United States, providing fresh impetus for one of its...

Positive developments in oncology and an analyst upgrade are providing a lift for GE Healthcare Technologies shares as the company...

As it enters the 2026 fiscal year, Agilent Technologies is sharpening its strategic focus on technological specialization and operational efficiency....

Investors are preparing for a detailed look at Twist Bioscience's operational health when the synthetic biology specialist releases its full...